Sebastian Szmit: Important Review Published Today By My Research Group
Sebastian Szmit, Head of Department of Cardio-Oncology, Centrum Medycznego Kształcenia Podyplomowego, shared on LinkedIn:
”Important review published today by my research group”
This review explores treatment options for venous thromboembolism (VTE) in cancer patients with significant thrombocytopenia (platelet count <50 × 10⁹/L), balancing the need for effective anticoagulation against the increased risk of bleeding.
It outlines strategies such as adjusting anticoagulation doses, using platelet transfusions, or temporarily stopping treatment based on the severity and duration of thrombocytopenia and the patient’s thrombotic risk.
Read the full article here.
Article: Anticoagulant therapy in patients with cancer and thrombocytopenia
Authors: Sebastian Szmit, Jarosław Kępski, Ewa Lech-Marańda, Dariusz M. Kowalski, Maciej Krzakowski, Magdalena Zaborowska-Szmit
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 25, 2026, 15:42Francesco Lo Monaco on Heart Disease Starting Quiet While Your Labs Speak First
-
Jan 25, 2026, 15:33Wilfried Dinh: Why Heart Patients Still Have Events Despite ”Optimal” Cardiovascular Therapy
-
Jan 25, 2026, 15:25Muhammad Ibrahim on Efficacy and Safety of Extended DOACs Use in VTE
-
Jan 25, 2026, 15:08Tushar Pandey on Managing Thrombotic Thrombocytopenic Purpura
-
Jan 25, 2026, 14:55Carolina Contreras Cuevas Shares a Nationwide Study on VTE in PAD
-
Jan 25, 2026, 14:40Jeannie Devereaux Links PRP and Physical Therapy
-
Jan 25, 2026, 14:25Heghine Khachatryan on Anticoagulation After AFib Ablation: New Evidence from NEJM
-
Jan 25, 2026, 12:42Lale Tokgözoğlu on Cardiovascular Risk Factors in Women
-
Jan 25, 2026, 12:32Dino Mehic on Bleeding Assessment Tools and QoL in BDUC